Clinical trials are the pinnacle of cancer research to evaluate breakthroughs in discovery science and determine if they’re effective in treating cancer.
Following our research strategy refresh in 2022, our new clinical research statement of intent emphasises asking mechanistic questions within our trials to advance our biological understanding of cancer and treatments.
Our Head of Clinical Research, Graham Cadwallader writes about the changes we’re making to the way we fund clinical research, which will provide flexible, modular and scalable funding that makes it easier for clinicians and discovery researchers to collaborate.
|